Latham & Watkins Assists Consortium Led by Astorg and Cinven in Securing CFIUS Clearance for LGC acquisition

CFIUS concluded that there were no unresolved national security issues with respect to the consortium’s acquisition of LGC.

April 21, 2020

A private equity consortium jointly led by Astorg Partners and Cinven received clearance from the Committee on Foreign Investment in the United States (CFIUS) in connection with its acquisition of LGC, a global leader in the life sciences tools sector that provides a comprehensive range of measurement tools, proficiency testing schemes, supply chain assurance standards, and specialty genomics reagents underpinned by leading analytical and measurement science capabilities. CFIUS concluded that there were no unresolved national security issues with respect to the transaction.

Latham & Watkins LLP represents the consortium led by Astorg and Cinven in the transaction and advised the company on the CFIUS clearance process. The CFIUS team was led by Washington, D.C. partner Les Carnegie and counsel Rachel Alpert, with associate Julie Choi Shin. The corporate deal team is led by London partners Thomas Forschbach, Tom Evans, Jay Sadanandan, and Neil Campbell.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.